Yoshikatsu Kanai

14PUBLICATIONS
35CO-AUTHORS
Proteomics and intermolecular interactions (excl. medical proteomics)Environmental nanotechnology and nanometrologyMicrobial taxonomyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 10, 2026
A Sensitive, Specific, and Cost-Effective Lauroylation-Assisted Workflow for Profiling Peptide-Level Protease Specificity Using Proteomic Identification of Cleavage Sites (PICS), with Applicability to Protein-Level N-Terminomics.

Hiroki Okanishi, Isayuki Uno, Sho-Ichi Nishimura

|Nov 21, 2025
Biosynthesis and Export of Membrane-Enveloped Selenium Nanoparticles by Escherichia coli.

Anna Ochi, Kano Shibamoto, Yosuke Toyotake

|Sep 15, 2025
Phosphomimetic mutations near active sites of proteins in Thermus thermophilus suggest a widespread regulatory mechanism.

Anzu Nishiwaki, Hiroki Okanishi, Yoshikatsu Kanai

|Feb 14, 2025
Structural basis of anticancer drug recognition and amino acid transport by LAT1.

Yongchan Lee, Chunhuan Jin, Ryuichi Ohgaki

|Apr 24, 2024
The LAT1 inhibitor JPH203 suppresses the growth of castration-resistant prostate cancer through a CD24-mediated mechanism.

Shinpei Saito, Keisuke Ando, Shinichi Sakamoto

|Jan 08, 2024
L-type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel-resistant prostate cancer by inhibiting cyclin-dependent kinase activity.

Junryo Rii, Shinichi Sakamoto, Atsushi Mizokami

Pageof 3

Frequent Collaborators

3 joint publications

Ryuichi Ohgaki

3 joint publications

Junryo Rii

3 joint publications

Shinichi Sakamoto

3 joint publications

Yasutaka Yamada